I firmly believe Hayward has been approached about a merger, at least. Note his comment about the shelf offering as a poison pill. There must have been a few inquiries to warrant that. Not sure about disclosure rules, but pretty sure Hayward listened to the lawyers and didn't fracture any SEC rulings.